Precise Oncology Interventions in Nutrition and Training (OnPoint)
Launched by UNIVERSITY OF MIAMI · Jul 30, 2024
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
The OnPoint clinical trial is looking at whether cancer survivors, specifically those who have had breast, prostate, or colorectal cancer, can improve their eating habits and increase their physical activity with the help of a personalized nutrition and exercise program. The study is currently recruiting participants aged 18 and older who are at least six months post-treatment and have no signs of active cancer. To be eligible, participants must also have internet access and be able to understand English or Spanish.
If you join the study, you will be randomly assigned to one of the groups in the trial, which means you might receive the nutrition and exercise support or be in a different group for comparison. Participating could involve completing some surveys and interviews about your health and habits. This is an important opportunity to see how targeted support can help cancer survivors lead healthier lifestyles.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Inclusion Criteria - Healthcare Providers
- • 1. Provide full- or part-time care in an oncology clinical care setting at Sylvester Comprehensive Cancer Center
- • 2. Utilize the electronic medical record for patient documentation on a regular basis
- • 3. Willing to complete a 60-90-minute interview
- • Inclusion Criteria - Patients
- • 1. 18 years of age or older
- • 2. Any sex/gender
- • 3. Able to provide consent
- • 4. Able to read/understand English or Spanish
- • 5. Diagnosis of breast, prostate or colorectal cancer, 6 months post competition of primary treatment, with no evidence of primary disease
- • 6. Approval from treating oncologist, confirmed via email or in writing
- • 7. Internet access on a smart phone, tablet, or computer
- • 8. Agree to be randomly assigned to any study group
- Exclusion Criteria:
- • 1. Less than 18 years of age
- • 2. Unable to provide consent
- • 3. Unable to read/understand English or Spanish
- • 4. Any contraindication for diet change or exercising as determined by physician
- • 5. Blank
- • 6. Engaging in \>150 minutes of moderate to vigorous physical activity on average per week for the prior month
- • 7. Meeting the American Cancer Society diet recommendations (3 cups of vegetables or legumes, 2 cups of fruit, 2 serving whole grain per day, and limited red/processed meats, sugar-sweetened beverages, and highly processed foods) for the prior month
- • 8. History of dementia or major psychiatric disease which would interfere with study participation
- • 9. History of recent (≤1 yr) stroke, myocardial infarction or congestive heart failure
- • 10. Eastern Cooperative Oncology Group (ECOG) score of \>2
- • 11. Severe lymphedema as determined by physician
- • 12. Receiving physical therapy treatment
About University Of Miami
The University of Miami, a leading academic institution, is dedicated to advancing medical research and improving patient care through innovative clinical trials. With a commitment to excellence in education and research, the university fosters collaboration among multidisciplinary teams to explore new therapies and treatment modalities. Its extensive clinical programs are supported by state-of-the-art facilities and a diverse patient population, enabling the exploration of cutting-edge solutions to complex health challenges. The University of Miami is poised to contribute significantly to the field of medicine through its rigorous scientific inquiry and a steadfast commitment to ethical research practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Miami, Florida, United States
Patients applied
Trial Officials
Tracy Crane, PhD, RDN
Principal Investigator
University of Miami
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported